Dec 18 2024 32 mins 1
Dr. Nisim Perets is the co-founder and CEO of Itay&Beyond (itayandbeyond.com). An Israeli biotech startup that integrates patient-derived brain organoids with advanced AI analysis to predict drug efficacy for neurological and psychiatric disorders. Their platform aims to improve drug development by providing accurate human-based models, reducing reliance on animal testing, and enhancing patient outcomes.
Avraham sat down with Nisim in the offices of Itay&Beyond to discuss what it means to use a patient’s braincells for testing drugs, how they came up with the idea, how the company was funded, tips for startup founders and much more.
Do you have a great innovation? We'd love to hear from you. Contact us by going to https://jmbdavis.com/startup/contact. Learn more at https://jmbdavis.com and https://jmbdavis.com/startup.
Also available at https://soundcloud.com/jmbdavis/itay-beyond. Listen to all of the episodes at https://jmbdavis.com/podcast.
Avraham sat down with Nisim in the offices of Itay&Beyond to discuss what it means to use a patient’s braincells for testing drugs, how they came up with the idea, how the company was funded, tips for startup founders and much more.
Do you have a great innovation? We'd love to hear from you. Contact us by going to https://jmbdavis.com/startup/contact. Learn more at https://jmbdavis.com and https://jmbdavis.com/startup.
Also available at https://soundcloud.com/jmbdavis/itay-beyond. Listen to all of the episodes at https://jmbdavis.com/podcast.
